What is Oblean used for?

Oblean is indicated for Obesity.

What development phase is Oblean in?

Oblean is FDA-approved (marketed).

What is the generic name of Oblean?

CETILISTAT is the generic (nonproprietary) name of Oblean.

Last reviewed 2026-05-15 · How we verify

Oblean (CETILISTAT)

FDA-approved active Small molecule Quality 17/100

At a glance

Generic name	CETILISTAT
Target	Pancreatic triacylglycerol lipase
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

Obesity

Common side effects

No common side effects on file.

Key clinical trials

Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects (PHASE1)
Efficacy and Safety of ATL-962 in Obese Diabetics (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oblean CI brief — competitive landscape report
Oblean updates RSS · CI watch RSS